Arcadia Biosciences, Inc. (RKDA) Capital expenditures 2017–2025
Arcadia Biosciences, Inc. (RKDA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2017: $79,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $16,000 | +220.0% |
| FY2023 | $5,000 | -93.1% |
| FY2022 | $72,000 | -92.9% |
| FY2021 | $1.0M | -56.9% |
| FY2020 | $2.3M | +58.1% |
| FY2019 | $1.5M | +490.8% |
| FY2018 | $250,000 | +216.5% |
| FY2017 | $79,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice